Overview

Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]

Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Open, multicenter, single arm, phase II, biomarker driven umbrella trial for head and neck squamous cell carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Chungnam National University Hospital
Korean Cancer Study Group
Treatments:
Antibodies, Monoclonal
Durvalumab
Nintedanib
Tremelimumab